hepatocellular carcinoma marcotolo type cancer hepatolog gastroenterolog infobox diseas hepatocellular carcinoma hepatocellular carcinoma individu wa hepat posit autopsi specimen med hepatocellular carcinoma hepatocellular carcinoma hcc call hepatoma primari malign cancer liver case hcc secondari viral hepatitid infect hepat cirrhosi alcohol common caus hepat cirrhosi countri hepat endem malign cancer liver primari hcc metastasi spread cancer elsewher bodi eg colon treatment option hcc prognosi depend mani factor especi tumor size stage tumor grade import highgrad tumor will poor prognosi lowgrad tumor unnot mani year case mani organ breast ductal carcinoma situ lobular carcinoma situ ani clinic sign correl routin imag test occas detect special imag studi mammographi howev sensit thi techniqu remain current stateoftheart technolog usual outcom poor becaus onli hepatocellular carcinoma remov complet surgeri cancer complet remov diseas usual deadli month thi partial late larg tumour lack medic expertis facil thi rare tumor unit receptor tyrosin kinas inhibitor sorafenib ha spanish phase iii clinic trial doubl lifespan late stage hcc patient epidemiolog hcc common tumor worldwid epidemiolog hcc exhibit main pattern north america western europ anoth nonwestern countri subsaharan africa central southeast asia amazon basin male affect femal usual common decad life hepatocellular carcinoma caus death worldwid year half china nonwestern countri subsaharan africa southeast asia hcc common cancer gener affect men women age onset late teen thi variabl differ pattern hepat transmiss differ popul infect birth predispos earlier cancer peopl infect time hepat infect develop hcc year decad diagnosi hcc death averag surviv period onli month accord chines studi dure month median surviv time subsaharan africa accord manson textbook tropic diseas hcc deadliest cancer china food infect aspergillu flavu especi peanut corn store dure prolong wet season produc aflatoxin pose anoth risk factor hcc north america western europ malign tumor liver discov western patient metastas spread tumor elsewher west hcc gener rare cancer normal preexist liver diseas detect ultrasound screen discov healthcar facil earlier develop region subsaharan africa acut chronic hepat porphyria acut intermitt porphyria porphyria cutanea tarda hereditari coproporphyria varieg porphyria tyrosinemia type risk factor hepatocellular carcinoma diagnosi acut hepat porphyria aip hcp vp sought patient hepatocellular carcinoma typic risk factor hepat alcohol liver cirrhosi hemochromatosi activ latent genet carrier acut hepat porphyria risk thi cancer latent genet carrier develop cancer age classic symptom patient acut hepat porphyria monitor hepatocellular carcinoma pathogenesi main articl carcinogenesi hepatocellular carcinoma ani cancer develop mutat cellular machineri caus cell replic higher rate andor result cell avoid apoptosi chronic infect hepat andor aid develop hepatocellular carcinoma repeatedli caus bodi immun system attack liver cell infect viru mere bystand thi constant cycl damag follow repair lead mistak dure repair turn lead carcinogenesi thi hypothesi applic hepat hepat howev integr viral genom infect cell consist associ factor malign altern repeat consumpt larg amount ethanol toxin aflatoxin aspergillu speci fungu carcinogen aid carcinogenesi hepatocellular cancer build liver combin high preval rate aflatoxin hepat countri china western africa ha led rel high rate heptatocellular carcinoma region viral hepatitid hepat potenti becom chronic infect thu relat hepatocellular carcinoma diagnosi screen monitor hepatocellular carcinoma hcc commonli appear patient chronic viral hepat hepat hepat cirrhosi patient commonli undergo surveil ultrasound costeffect patient higher suspicion hcc rise alphafetoprotein desgamma carboxyprothrombin level best method diagnosi involv ct scan abdomen intraven contrast agent threephas scan befor contrast administr immedi contrast administr delay increas abil radiologist detect small subtl tumor import optim paramet ct examin becaus underli liver diseas hcc patient find difficult appreci ct hcc three distinct pattern growth singl larg tumor multipl tumor poorli defin tumor infiltr growth pattern onc imag diagnosi confirm percutan biopsi histopatholog analysi key characterist ct hypervascular arteri phase scan washout deenhanc portal delay phase studi pseudocapsul mosaic pattern calcif intralesion fat appreci ct scan contrast agent typic iodin barium base patient allerg contrast agent iodin usual allerg reaction manag life threaten altern ct imag studi mri mri expens avail becaus fewer facil mri machin import mri tumor detect fewer radiologist skill find tumor mri studi screen devic mostli radiologist mri secondari studi area tumor ha alreadi detect mri contrast agent best detail liver tumor veri iron oxid nanoparticl appear better result absorb normal liver tissu tumor scar tissu patholog macroscop liver cancer appear nodular infiltr tumor nodular type solitari larg mass multipl develop complic cirrhosi tumor nodul round oval grey green tumor produc bile well circumscrib encapsul diffus type poorli circumscrib infiltr portal vein hepat vein rare microscop architectur cytolog type pattern hepatocellular carcinoma fibrolamellar pseudoglandular adenoid pleomorph giant cell clear cell well differenti form tumor cell resembl hepatocyt form trabecula cord nest bile pigment cytoplasm poorli differenti form malign epitheli cell discohes pleomorph anaplast giant tumor ha scant stroma central necrosi becaus poor vascular stage prognosi import featur guid treatment includ size spread stage involv liver vessel presenc tumor capsul presenc extrahepat metastas presenc daughter nodul vascular tumor mri best imag method detect presenc tumor capsul treatment liver transplant replac liver cadav liver live donor lobe histor low surviv rate improv relat adopt milan criteria transplant center tumor diseas ha metastas immunosuppress posttranspl drug decreas chanc surviv surgic resect remov tumor treat small slowgrow tumor diagnos earli thi treatment offer best prognosi longterm surviv unfortun possibl onli case resect cirrhot patient carri high morbid mortal percutan ethanol inject pei well toler high rr small cm solitari tumor random trial compar resect percutan treatment recurr rate postresect transcathet arteri chemoembol tace usual perform treatment larg tumor larger cm cm diamet frequent intraarteri inject infus antineoplast agent mix iodiz oil lipiodol multipl trial object tumor respons slow tumor progress question surviv benefit compar support care greatest benefit patient preserv liver function absenc vascular invas smallest tumor seal sourc radiotherapi destroy tumor thu minim exposur healthi tissu theraspher fda approv treatment ha clinic trial increas surviv rate lowrisk patient thi method cathet insert radiologist deposit radioact particl area interest radiofrequ ablat rfa high frequenc radiowav ablat tumour intraarteri administr efficaci demonstr unresect patient portal vein thrombu thi treatment adjuv therapi resect patient lau believ rais surviv rate thi adjuv therapi phase iii clinic trial singapor avail standard medic treatment qualifi patient hong kong combin pei tace tumor larger cm diamet italian group success larger tumour tace alon high intens focus ultrasound hifu confus normal diagnost ultrasound techniqu power ultrasound treat tumour veri experiment stage work ha china earli work oxford london uk hormon therapi antiestrogen therapi tamoxifen studi sever trial mix result studi gener consid ineffect octreotid somatostatin analogu ms ms untreat patient small random studi result reproduc adjuv chemotherapi random trial benefit neoadjuv adjuv system therapi hcc singl trial decreas tumor patient receiv oral synthet retinoid month resect ablat result reproduc clinic trial vari result palli regimen includ doxorubicin cisplatin fluorouracil interferon epirubicin taxol singl agent combin ani surviv benefit rr isol major respons allow patient undergo partial hepatectomi publish result ani random trial system chemotherapi cryosurgeri cryosurgeri techniqu destroy tumor varieti site brain breast kidney prostat liver cryosurgeri destruct abnorm tissu subzero temperatur tumor remov destroy cancer left reabsorb bodi initi result properli select patient unresect liver tumor equival resect cryosurgeri involv placement stainless steel probe center tumor liquid nitrogen circul thi devic tumor half inch margin normal liver frozen minut lethal tissu area thaw minut refrozen anoth minut tumor ha thaw probe remov bleed control procedur complet patient will spend postop night intens care unit typic discharg day proper select patient attent detail perform cryosurg procedur mandatori order achiev good result outcom frequent cryosurgeri conjunct liver resect tumor remov treat cryosurgeri patient insert hepat intraarteri arteri cathet postop chemotherapi liver resect surgeon experi cryosurg techniqu order provid best treatment possibl drug sorafenib wa origin renal cell cancer ha promis result hepatocellular cancer intervent radiolog abbrevi hcc hepatocellular carcinoma tace transarteri embolizationchemoembol pf progressionfre surviv ps perform statu hbv hepat viru pei percutan ethanol inject rr respons rate ms median surviv awar jade ribbon campaign awar liver cancer hepat pacif island ill widespread elsewher futur direct current includ search gene disregul hcc protein marker predict biomark yield result variou malign diseas hope identifi aberr gene result protein lead identif pharmacolog intervent hcc addit imag hepatocellular carcinoma histopatholog jpg hepatocellular carcinoma histopatholog higher magnificationjpg refer kumar fausto abba editor robbin cotran patholog basi diseas saunder isbn hepatocellular carcinoma medlineplu medic encyclopedia cancer health organ februari retriev hepatocellular carcinoma photo atla patholog american societi clinic oncolog annual meet abstract hepatobiliari cancer genet hcc stanford asian liver center huntington medic institut news journal clinic oncolog special issu molecular oncolog receptorbas therapi april lau leung ho chan machin lau chan yeo mok yu leung johnson adjuv intraarteri lipiodol resect hepatocellular carcinoma prospect randomis trial lancet doi pmid thoma zhu hepatocellular carcinoma progress clin oncol doi pmid extern link nci liver cancer homepag blue faeri adrienn wilson liver cancer associ liver cancer overview mayo clinic digest system digest diseas gastroenterolog primarili upper gi tract esophagu esophag candid ruptur boerhaav syndrom malloryweiss syndrom ue zenker diverticulum le barrett esophagu esophag motil disord nutcrack esophagu achalasia diffus esophag spasm gerd esophag strictur megaesophagu stomach gastriti atroph mntrier diseas gastroenter peptic gastric ulcer cush ulcer dieulafoy lesion dyspepsia pylor stenosi achlorhydria gastroparesi gastroptosi portal hypertens gastropathi gastric antral vascular ectasia gastric dump syndrom gastric volvulu intestin enteropathi small intestin duodenum jejunum ileum enter duoden jejun ileiti peptic duoden ulcer curl ulcer malabsorpt coeliac tropic sprue blind loop syndrom whippl short bowel syndrom steatorrhea larg intestin appendix colon append coliti pseudomembran ulcer ischem microscop collagen lymphocyt function colon diseas ib intestin pseudoobstruct ogilvi syndrom megacolon toxic megacolon diverticul diverticulosi larg andor small enterocol necrot ibd crohn diseas vascular abdomin angina mesenter ischemia angiodysplasia bowel obstruct ileu intussuscept volvulu fecal impact constip diarrhea rectum anu proctiti radiat proctiti proctalgia fugax rectal prolaps anal fissur anal fistula anal abscess accessori liver hepat viral hepat autoimmun hepat alcohol hepat cirrhosi pbc fatti liver nash vascular hepat venoocclus diseas portal hypertens nutmeg liver alcohol liver diseas liver failur hepat encephalopathi acut liver failur liver abscess hepatoren syndrom peliosi hepati gallbladd cholecyst gallston cholecystolithiasi cholesterolosi rokitanskyaschoff sinus postcholecystectomi syndrom bile duct other biliari tree cholang psc ascend cholestasi mirizzi syndrom biliari fistula haemobilia gallston cholelithiasi common bile duct choledocholithiasi biliari dyskinesia pancreat pancreat acut chronic hereditari pancreat pseudocyst exocrin pancreat insuffici pancreat fistula hernia diaphragmat congenit diaphragmat hiatu abdomin hernia inguin indirect direct umbil incision femor obtur hernia spigelian hernia periton periton spontan bacteri periton hemoperitoneum pneumoperitoneum gi bleed upper hematemesi melena lower hematochezia tumor digest system neoplasia tract upper esophagu adenocarcinoma squamou cell carcinoma stomach gastric carcinoma signet ring cell carcinoma gastric lymphoma liniti plastica lower small intestin appendix carcinoid pseudomyxoma peritonei colonrectum hereditari nonpolyposi colorect cancer polyp colorect polyp peutzjegh syndrom juvenil polyposi syndrom famili adenomat polyposi cronkhitecanada diseas anu upper lower gastrointestin stromal tumor accessori liver tumor malign hepatocellular carcinoma fibrolamellar hepatoblastoma benign hepatocellular adenoma cavern angioma hyperplasia focal nodular hyperplasia nodular regen hyperplasia biliari tract neoplasm bile duct cholangiocarcinoma klatskin tumor gallbladd gallbladd cancer pancrea exocrin pancrea adenocarcinoma pancreat ductal carcinoma pancreatoblastoma peritoneum primari periton cancer epitheli neoplasm icdo papilloma carcinoma small cell carcinoma verruc carcinoma squamou cell carcinoma basal cell carcinoma transit cell carcinoma invert papilloma adenoma adenocarcinoma liniti plastica pancrea insulinoma glucagonoma gastrinoma vipoma somatostatinoma neuroendocrin tumor cholangiocarcinoma hepatocellular adenoma hepatocellular carcinoma adenoid cystic carcinoma famili adenomat polyposi prolactinoma oncocytoma hurthl cell clear cell adenomaadenocarcinoma renal cell carcinoma multipl endocrin neoplasia endometrioid tumor apudoma klatskin tumor carcinoid cylindroma adrenocort adenoma adrenocort carcinoma papillari hidradenoma adnexa skin appendag sweat gland hidrocystoma syringoma cystic mucin serou mucoepidermoid carcinoma cystadenoma cystadenocarcinoma pseudomyxoma peritonei signet ring cell carcinoma krukenberg tumor ductal lobular medullari ductal carcinoma comedocarcinoma paget diseas breast extramammari paget diseas acinar cell acin cell carcinoma complex epitheli warthin tumor thymoma gonad sex cordstrom tumour thecoma granulosa cell tumour luteoma sertolileydig cell tumour paraganglioma glomu tumor paraganglioma pheochromocytoma glomu tumor nevi melanoma melanocyt nevu dysplast nevu halo nevu nodular melanoma lentigo maligna melanoma superfici spread melanoma acral lentigin melanoma